← feed

Is NCT04498702 results overdue?

Yes — results are overdue. Primary completion was 2017-01-18; the FDAAA-801 reporting deadline (2018-01-18) passed 3076 days ago and no results are posted on ClinicalTrials.gov.

Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy

NCT IDNCT04498702 ↗
SponsorJiangsu Yahong Meditech Co., Ltd aka Asieris (INDUSTRY)
PhasePHASE2
StatusCOMPLETED
Primary completion2017-01-18 (ACTUAL)
Reporting deadline2018-01-18 (completion + 365d)
Days overdue3076
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 2c3f81f99c9364b9… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04498702. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →